Xeris Biopharma Ownership | Who Owns Xeris Biopharma?
Xeris Biopharma Ownership Summary
Xeris Biopharma is owned by 64.21% institutional investors, 3.12% insiders, and 32.67% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.52% of XERS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.01% of its assets in Xeris Biopharma shares.
XERS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Xeris Biopharma | 64.21% | 3.12% | 32.67% |
| Sector | Healthcare Stocks | 50.49% | 12.37% | 37.14% |
| Industry | Biotech Stocks | 48.95% | 12.07% | 38.98% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 14.53M | 8.52% | $115.04M |
| Blackrock | 10.33M | 7.35% | $23.25M |
| Vanguard group | 11.19M | 6.30% | $87.82M |
| D. e. shaw | 7.80M | 4.58% | $61.81M |
| Vanguard capital management | 7.34M | 4.30% | $58.13M |
| State street | 4.82M | 2.83% | $38.19M |
| Geode capital management | 4.72M | 2.77% | $37.37M |
| Nuveen | 4.39M | 2.57% | $34.73M |
| Rosalind advisors | 2.91M | 1.71% | $23.04M |
| Qube research | 2.89M | 1.70% | $22.92M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rosalind advisors | 2.91M | 8.56% | $23.04M |
| Knott david m jr | 1.06M | 4.44% | $8.40M |
| Parkman healthcare partners | 1.81M | 1.47% | $14.32M |
| Essex investment management | 715.61K | 0.74% | $5.67M |
| Cliffwater | 263.16K | 0.52% | $2.08M |
| Redmile group | 451.10K | 0.36% | $3.67M |
| Virtus investment advisers | 171.26K | 0.32% | $1.36M |
| Alphacentric advisors | 46.55K | 0.31% | $368.67K |
| Granahan investment management | 898.75K | 0.25% | $7.12M |
| Armistice capital | 1.96M | 0.19% | $15.51M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 14.53M | 0.00% | 1.58M |
| Sixth street partners management company | 1.49M | 0.00% | 1.49M |
| Nuveen | 4.39M | 0.01% | 1.47M |
| Vanguard group | 11.19M | 0.00% | 1.36M |
| Dimensional fund advisors lp | 1.07M | 0.00% | 1.07M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bioimpact capital | - | - | -4.83M |
| Aigh capital management | - | - | -2.57M |
| Millennium management | 131.66K | 0.00% | -2.13M |
| Caxton | - | - | -2.02M |
| Voss capital | - | - | -1.39M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sixth street partners management company | 1.49M | 0.00% | 1.49M | $11.82M |
| Dimensional fund advisors lp | 1.07M | 0.00% | 1.07M | $8.50M |
| Norges bank | 797.20K | 0.00% | 797.20K | $6.31M |
| Walleye capital | 611.30K | 0.02% | 611.30K | $4.84M |
| First trust advisors lp | 484.98K | 0.00% | 484.98K | $3.84M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -27.00 |
| Bryn mawr trust | -40.00 |
| Wealthtrak capital management | -40.00 |
| American capital advisory | -50.00 |
| Stephens consulting | -65.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 246 | 0.82% | 109,496,063 | 4.08% | 64 | 1.60% | 145 | - | 62 | 12.73% |
| Mar 31, 2026 | 241 | 3.88% | 105,125,006 | 4.27% | 65 | 2.03% | 144 | 24.14% | 55 | -26.67% |
| Dec 31, 2025 | 156 | -34.18% | 64,478,323 | -33.69% | 36 | 0.93% | 74 | -46.76% | 51 | -15.00% |
| Sep 30, 2025 | 137 | -33.50% | 56,532,097 | -37.58% | 36 | 1.07% | 80 | -25.23% | 33 | -43.10% |
| Jun 30, 2025 | 205 | - | 90,532,231 | 4.30% | 58 | 1.79% | 106 | -17.83% | 58 | 45.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 5.19M | 3.01% | 241.60K |
| Vanguard Morn Total Stk Mkt Idx Investor | 5.19M | 3.01% | 241.60K |
| Vanguard MStar Total Stk Mkt Idx Invest | 5.19M | 2.85% | - |
| Vanguard US Total Market Shares ETF | 4.25M | 2.76% | - |
| iShares Russell 2000 ETF | 4.36M | 2.39% | -77.38K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.99M | 1.09% | 3.54K |
| CREF Total Global Stock Account R3 | 1.95M | 1.07% | 167.57K |
| CREF Stock R1 | 1.48M | 0.96% | - |
| Fidelity Small Cap Index | 1.57M | 0.91% | 3.75K |
| iShares Russell 2000 Growth ETF | 1.54M | 0.85% | -14.15K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 12, 2026 | Pieper Steven | See Remarks | Sell | $42.50K |
| Aug 03, 2026 | McCulloch Kevin | See Remarks | Sell | $120.24K |
| Aug 03, 2026 | Hecht Beth | See Remarks | Sell | $133.55K |
| Jul 07, 2026 | Pieper Steven | See Remarks | Sell | $235.28K |
| Jul 06, 2026 | Pieper Steven | See Remarks | Sell | $147.90K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 7 |
| 2026 Q2 | - | 7 |
| 2026 Q1 | - | 7 |
| 2025 Q4 | - | 5 |
| 2025 Q3 | - | 4 |
XERS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools